Literature DB >> 6255865

Effect of beta-lactamase and salt on mecillinam susceptibility of enterobacterial strains.

G P Bongaerts, K M Bruggeman-Ogle.   

Abstract

Out of 15 selected enterobacterial strains resistant to ampicillin, 12 were able to transfer resistance to mecillinam to Escherichia coli K-12. This resistance to mecillinam was found to be coupled to the presence of beta-lactamase. One strain contained a beta-lactamase characterized as a class IV beta-lactamase, whereas the other 14 strains possessed a class III (TEM-like) beta-lactamase. The specific activity of the class IV beta-lactamase against mecillinam was 55%, and those of the class III beta-lactamase sensitivity of mecillinam, the minimal inhibitory concentrations were lower than might be expected. However, after enzymatic hydrolysis of mecillinam, no antibacterial activity was found. At increasing salt or buffer concentrations the minimal inhibitory concentrations of mecillinam increase to a varying extent for all strains, independently of beta-lactamase production. This study indicates that the increase in minimal inhibitory concentration is dependent on the salt concentration. The study also shows that this increase is not due to salt-mediated hydrolysis or to stimulation either of beta-lactamase activity or of beta-lactamase production. To explain the difference between ampicillin and mecillnam resistance in the beta-lactamase-positive strains, a hypothetical model is presented and discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6255865      PMCID: PMC284075          DOI: 10.1128/AAC.18.5.680

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Inhibition of an early event in the cell division cycle of Escherichia coli by FL1060, an amidinopenicillanic acid.

Authors:  R James; J Y Haga; A B Pardee
Journal:  J Bacteriol       Date:  1975-06       Impact factor: 3.490

2.  Mapping of the mecillinam-resistant, round morphological mutants of Escherichia coli.

Authors:  M Iwaya; C W Jones; J Khorana; J L Strominger
Journal:  J Bacteriol       Date:  1978-01       Impact factor: 3.490

Review 3.  Mecillinam resistance in clinical practice--a review.

Authors:  J D Anderson
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

4.  The mechanism of action of mecillinam.

Authors:  B G Spratt
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

5.  Activity of FL 1060, a new beta-lactam antibiotic, against urinary tract pathogens.

Authors:  D Greenwood; H L Brooks; R Gargan; F O'Grady
Journal:  J Clin Pathol       Date:  1974-03       Impact factor: 3.411

6.  FL-1060: a new penicillin with a unique mode of action.

Authors:  J T Park; L Burman
Journal:  Biochem Biophys Res Commun       Date:  1973-04-16       Impact factor: 3.575

7.  6 -amidinopenicillanic acids--a new group of antibiotics.

Authors:  F Lund; L Tybring
Journal:  Nat New Biol       Date:  1972-04-05

8.  In vitro studies with mecillinam on Escherichia coli and Pseudomonas aeruginosa.

Authors:  M H Richmond
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

9.  Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitro.

Authors:  L Tybring; N H Melchior
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

10.  Mechanism of action and development of resistance to a new amidino penicillin.

Authors:  S Matsuhashi; T Kamiryo; P M Blumberg; P Linnett; E Willoughby; J L Strominger
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

View more
  2 in total

1.  Aminoglycoside phosphotransferase-II-mediated amikacin resistance in Escherichia coli.

Authors:  G P Bongaerts; G M Kaptijn
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

2.  Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci.

Authors:  A Thabaut; J L Durosoir; P Saliou
Journal:  Infection       Date:  1982       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.